UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles

Molecular cancer, 2018-12, Vol.17 (1), p.177-177, Article 177

2018

Volltextzugriff (PDF)

Immunomodulatory Drugs (IMiDs) in Multiple Myeloma

Current cancer drug targets, 2017-01, Vol.17 (9), p.846-1

2017

Volltextzugriff (PDF)

Analysis of risk factors and prognostic factors of brain metastasis in gastric cancer: a surveillance, epidemiology and end-results database study

Scientific reports, 2023-10, Vol.13 (1), p.18664-18664, Article 18664

2023

Volltextzugriff (PDF)

A Challenging Case of Kaposi Sarcoma Inflammatory Cytokine Syndrome

Curēus (Palo Alto, CA), 2023-07

2023

Volltextzugriff (PDF)

Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation Phase

Clinical and applied thrombosis/hemostasis, 2023-01, Vol.29, p.10760296231177678-10760296231177678

2023

Volltextzugriff (PDF)

Current Novel Targeted Therapeutic Strategies in Multiple Myeloma

International journal of molecular sciences, 2024-06, Vol.25 (11), p.6192

2024

Volltextzugriff (PDF)

Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management

Current oncology (Toronto), 2023-07, Vol.30 (7), p.6330-6352

2023

Volltextzugriff (PDF)

Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival

Journal of neurosurgery, 2009-01, Vol.110 (1), p.173-180

2009

Volltextzugriff (PDF)

A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma

Journal of neurosurgery, 2012-02, Vol.116 (2), p.341-345

2012

Volltextzugriff (PDF)

Comparative proteogenomic characterization of glioblastoma

CNS oncology, 2019-06, Vol.8 (2), p.CNS37

2019

Volltextzugriff (PDF)

Ocular complications of antineoplastic therapies

Future science OA, 2023-08, Vol.9 (7), p.FSO871-FSO871

2023

Volltextzugriff (PDF)

Vasovagal Syncope and Pulseless Electrical Activity Cardiac Arrest in Patients With Immunoglobulin Light Chain Cardiac Amyloidosis: A Case Series

Curēus (Palo Alto, CA), 2023-01

2023

Volltextzugriff (PDF)

Management of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice

Cancers, 2023-04, Vol.15 (7), p.2160

2023

Volltextzugriff (PDF)

COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review

Therapeutic Advances in Vaccines and Immunotherapy, 2023-01, Vol.11

2023

Volltextzugriff (PDF)

Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management

Journal of clinical medicine, 2024-03, Vol.13 (6), p.1744

2024

Volltextzugriff (PDF)

Recognizing acute promyelocytic leukemia in a patient with treated chronic lymphocytic leukemia

EJHaem, 2021-02, Vol.2 (1), p.20-22

2021

Volltextzugriff (PDF)

Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma

Blood cancer journal (New York), 2020-02, Vol.10 (2), p.13, Article 13

2020

Volltextzugriff (PDF)

Trametinib: Could It Be a Promising Drug to Treat Atypical Chronic Myeloid Leukemia?

Curēus (Palo Alto, CA), 2022-07

2022

Volltextzugriff (PDF)

The Critical Role of Imaging in the Management of Multiple Myeloma

Current hematologic malignancy reports, 2017-06, Vol.12 (3), p.168-175

2017

Volltextzugriff (PDF)

Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy

Blood cancer journal (New York), 2024-05, Vol.14 (1), p.90-9, Article 90

2024

Volltextzugriff (PDF)

Role of Palliative Care in the Supportive Management of AL Amyloidosis-A Review

Journal of clinical medicine, 2024-04, Vol.13 (7), p.1991

2024

Volltextzugriff (PDF)

Management of Adverse Reactions for BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review

Journal of clinical medicine, 2023-08, Vol.12 (17), p.5539

2023

Volltextzugriff (PDF)

Optimizing current and emerging therapies in multiple myeloma: a guide for the hematologist

Therapeutic Advances in Hematology, 2017-02, Vol.8 (2), p.55-70

2017

Volltextzugriff (PDF)

Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition

Npj genomic medicine, 2021-03, Vol.6 (1), p.23-23, Article 23

2021

Volltextzugriff (PDF)

Prone Hypofractionated Whole-Breast Radiotherapy Without a Boost to the Tumor Bed: Comparable Toxicity of IMRT Versus a 3D Conformal Technique

International journal of radiation oncology, biology, physics, 2012-03, Vol.82 (3), p.e415-e423

2012

Volltextzugriff (PDF)

1 – 25 von 716

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(521)
Mit Volltextzugriff
(557)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(349)
Life Sciences & Biomedicine
(183)
Technology
(108)
Physical Sciences
(97)
Humans
(78)
Chemistry
(69)
Engineering
(49)
Materials Science
(48)
Female
(46)
Male
(43)
Oncology
(35)
Materials Science, Multidisciplinary
(33)
Pakistan
(33)
Physics
(33)
Science & Technology - Other Topics
(32)
Pharmacology & Pharmacy
(31)
Chemistry, Multidisciplinary
(30)
Hematology
(30)
Patients
(28)
Middle Aged
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(9)
... seit 90 Tagen
(27)

Menü

Weitere Dienste

Einstellungen

Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles

Immunomodulatory Drugs (IMiDs) in Multiple Myeloma

Analysis of risk factors and prognostic factors of brain metastasis in gastric cancer: a surveillance, epidemiology and end-results database study

A Challenging Case of Kaposi Sarcoma Inflammatory Cytokine Syndrome

Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation Phase

Current Novel Targeted Therapeutic Strategies in Multiple Myeloma

Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management

Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival

A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma

Comparative proteogenomic characterization of glioblastoma

Ocular complications of antineoplastic therapies

Vasovagal Syncope and Pulseless Electrical Activity Cardiac Arrest in Patients With Immunoglobulin Light Chain Cardiac Amyloidosis: A Case Series

Management of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice

COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review

Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management

Recognizing acute promyelocytic leukemia in a patient with treated chronic lymphocytic leukemia

Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma

Trametinib: Could It Be a Promising Drug to Treat Atypical Chronic Myeloid Leukemia?

The Critical Role of Imaging in the Management of Multiple Myeloma

Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy

Role of Palliative Care in the Supportive Management of AL Amyloidosis-A Review

Management of Adverse Reactions for BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review

Optimizing current and emerging therapies in multiple myeloma: a guide for the hematologist

Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition

Prone Hypofractionated Whole-Breast Radiotherapy Without a Boost to the Tumor Bed: Comparable Toxicity of IMRT Versus a 3D Conformal Technique

Suchergebnisse filtern